WEKO3
アイテム
{"_buckets": {"deposit": "276d6fcd-d523-4dc5-95cc-cce3e538dc6c"}, "_deposit": {"created_by": 3, "id": "20345", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "20345"}, "status": "published"}, "_oai": {"id": "oai:twinkle.repo.nii.ac.jp:00020345", "sets": ["2027"]}, "author_link": ["296378", "296381", "296379", "296380"], "item_10001_alternative_title_1": {"attribute_name": "別タイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Expression of COX-2 in Gastrointestinal Cancer: As a Target for Cancer Prevention and Therapy (3) : Esophageal Cancer and COX-2"}]}, "item_10001_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2007-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "11", "bibliographicPageEnd": "557", "bibliographicPageStart": "553", "bibliographicVolumeNumber": "77", "bibliographic_titles": [{"bibliographic_title": "東京女子医科大学雑誌"}]}]}, "item_10001_creator_2": {"attribute_name": "著者名", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "吉松, 和彦"}], "nameIdentifiers": [{"nameIdentifier": "296378", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小川, 健治"}], "nameIdentifiers": [{"nameIdentifier": "296379", "nameIdentifierScheme": "WEKO"}]}]}, "item_10001_date_25": {"attribute_name": "受付日付", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2010-08-10", "subitem_date_issued_type": "Created"}]}, "item_10001_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Cyclooxygenase-2 (COX-2) derived prostaglandin (PG) E_2 is concerned with multiplication of intestinal cancer, in particular colorectal cancer, and has attracted attention as a preventive or therapeutic target of cancer. In the esophagus, COX-2 overexpression is reported in Barrett\u0027s epithelium, esophageal adenocarcinoma and squamous cell carcinoma. It has been suggested that patients with high COX-2 expression have poor prognosis. In squamous cell carcinoma of the esophagus, COX-2 expression is detected in the stage of dysplasia, and its expression is accompanied by enhanced proliferation activity and accumulation of p53. Compared with adenocarcinoma, however there is little correlation with clinicopathological factors. In a duodeno-gastric reflux rat model, COX-2 inhibitor can control the generation of cancer without inhibition of Barrett\u0027s esophagus. In a chemical carcinogenesis model, there are two conflicting reports about the effect of COX-2 inhibitor on the incidence and size of tumor. Since in vitro studies have shown that COX-2 inhibitor can block the proliferation of Barrett\u0027s derived cells and squamous carcinoma derived cells, COX-2 inhibitor is expected to have a preventive or therapeutic effect. Based on the results of clinical use of COX-2 inhibitor, its potential as cancer revention in patients with reflux esophagitis or Barrett\u0027s esophagus and as neoadjuvant therapy before surgery for esophageal cancer is suggested.", "subitem_description_type": "Abstract"}]}, "item_10001_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "296380", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "YOSHIMATSU, Kazuhiko"}]}, {"nameIdentifiers": [{"nameIdentifier": "296381", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "OGAWA, Kenji"}]}]}, "item_10001_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "東京女子医科大学学会"}]}, "item_10001_source_id_11": {"attribute_name": "NCID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00161368", "subitem_source_identifier_type": "NCID"}]}, "item_10001_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0040-9022", "subitem_source_identifier_type": "ISSN"}]}, "item_10001_subject_47": {"attribute_name": "著者キーワード", "attribute_value_mlt": [{"subitem_subject": "esophageal cancer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cyclooxygenase-2", "subitem_subject_scheme": "Other"}, {"subitem_subject": "prostaglandin E_2", "subitem_subject_scheme": "Other"}, {"subitem_subject": "COX-2 inhibitor", "subitem_subject_scheme": "Other"}]}, "item_10001_text_35": {"attribute_name": "著者所属", "attribute_value_mlt": [{"subitem_text_value": "東京女子医科大学東医療センター外科"}, {"subitem_text_value": "東京女子医科大学東医療センター外科"}]}, "item_10001_version_type_20": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-08-22"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KJ00006017945.pdf", "filesize": [{"value": "762.4 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 762400.0, "url": {"label": "KJ00006017945.pdf", "url": "https://twinkle.repo.nii.ac.jp/record/20345/files/KJ00006017945.pdf"}, "version_id": "3d9aac44-a5c6-477f-970f-b08acf31b8ff"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "消化器癌におけるCOX-2発現:発癌予防,治療の標的として(3) : 食道癌とCOX-2", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "消化器癌におけるCOX-2発現:発癌予防,治療の標的として(3) : 食道癌とCOX-2"}]}, "item_type_id": "10001", "owner": "3", "path": ["2027"], "permalink_uri": "http://hdl.handle.net/10470/27644", "pubdate": {"attribute_name": "公開日", "attribute_value": "2010-08-10"}, "publish_date": "2010-08-10", "publish_status": "0", "recid": "20345", "relation": {}, "relation_version_is_last": true, "title": ["消化器癌におけるCOX-2発現:発癌予防,治療の標的として(3) : 食道癌とCOX-2"], "weko_shared_id": -1}
消化器癌におけるCOX-2発現:発癌予防,治療の標的として(3) : 食道癌とCOX-2
http://hdl.handle.net/10470/27644
http://hdl.handle.net/10470/27644e8af5ae0-6789-4d9b-b870-8d6c9361bee6
名前 / ファイル | ライセンス | アクション |
---|---|---|
KJ00006017945.pdf (762.4 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-08-10 | |||||
タイトル | ||||||
タイトル | 消化器癌におけるCOX-2発現:発癌予防,治療の標的として(3) : 食道癌とCOX-2 | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
別タイトル | ||||||
その他のタイトル | Expression of COX-2 in Gastrointestinal Cancer: As a Target for Cancer Prevention and Therapy (3) : Esophageal Cancer and COX-2 | |||||
著者名 |
吉松, 和彦
× 吉松, 和彦× 小川, 健治 |
|||||
著者別名 | ||||||
姓名 | YOSHIMATSU, Kazuhiko | |||||
著者別名 | ||||||
姓名 | OGAWA, Kenji | |||||
出版者 | ||||||
出版者 | 東京女子医科大学学会 | |||||
受付日付 | ||||||
日付 | 2010-08-10 | |||||
日付タイプ | Created | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0040-9022 | |||||
NCID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00161368 | |||||
書誌情報 |
東京女子医科大学雑誌 巻 77, 号 11, p. 553-557, 発行日 2007-11 |
|||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Cyclooxygenase-2 (COX-2) derived prostaglandin (PG) E_2 is concerned with multiplication of intestinal cancer, in particular colorectal cancer, and has attracted attention as a preventive or therapeutic target of cancer. In the esophagus, COX-2 overexpression is reported in Barrett's epithelium, esophageal adenocarcinoma and squamous cell carcinoma. It has been suggested that patients with high COX-2 expression have poor prognosis. In squamous cell carcinoma of the esophagus, COX-2 expression is detected in the stage of dysplasia, and its expression is accompanied by enhanced proliferation activity and accumulation of p53. Compared with adenocarcinoma, however there is little correlation with clinicopathological factors. In a duodeno-gastric reflux rat model, COX-2 inhibitor can control the generation of cancer without inhibition of Barrett's esophagus. In a chemical carcinogenesis model, there are two conflicting reports about the effect of COX-2 inhibitor on the incidence and size of tumor. Since in vitro studies have shown that COX-2 inhibitor can block the proliferation of Barrett's derived cells and squamous carcinoma derived cells, COX-2 inhibitor is expected to have a preventive or therapeutic effect. Based on the results of clinical use of COX-2 inhibitor, its potential as cancer revention in patients with reflux esophagitis or Barrett's esophagus and as neoadjuvant therapy before surgery for esophageal cancer is suggested. | |||||
著者所属 | ||||||
東京女子医科大学東医療センター外科 | ||||||
著者所属 | ||||||
東京女子医科大学東医療センター外科 | ||||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | esophageal cancer | |||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | cyclooxygenase-2 | |||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | prostaglandin E_2 | |||||
著者キーワード | ||||||
主題Scheme | Other | |||||
主題 | COX-2 inhibitor |